A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer
{{output}}
Background: Mitochondrial permeability transition-driven necrosis (MPT-DN) is a therapeutic target and critical driver of prostate adenocarcinoma (PRAD) progression. We investigated MPT-DN-related prognostic features in PRAD. ... ...
